Paradice and Lew on their love of medical research – and Greece

Solomon Lew, the billionaire retailer, has known David Paradice, the high-profile fund managers, for years. Beyond investing, they share a common interest in medical research – and holidaying in Greece.
Picture: Solomon Lew & David Paradice

Jemima Whyte

Paradice and Lew on their love of medical research – and Greece

November 3, 2023
Solomon Lew, the billionaire retailer, has known David Paradice, the high-profile fund managers, for years. Beyond investing, they share a common interest in medical research – and holidaying in Greece.
Read Transcript

The Australian Financial Review’s Related Parties column will document the lesser known and more personal connections between the country’s prominent business figures. Solomon Lew, the billionaire retailer, has known David Paradice, the high-profile fund managers, for years. Beyond investing, they share a common interest in medical research – and holidaying in Greece.

Solomon Lew: I’ve known David for about 25 years. He has always struck me as extremely competent, accredited fund manager with great principles. And it reminds me of Columbo, that TV series, the guy in the raincoat with the newspaper. He’s always got the killer question.

David has always been a very charitable individual. He’s always front and centre. David is no piker. He’s right there. He’s the type of fellow that you can bring along, he doesn’t need a lot of convincing. David knows right from wrong and is an individual with a big heart.

We were in one of the [Greek] islands, and we were going to dinner. He says, “we’re never going to be able to cross this road. It’s terrible. It’s shocking. There are no lights, motorbikes screaming everywhere.” 

I said: “David, there’s one way to get across this particular roadway. We’re going to walk across this. The only thing I can offer you then is I can offer you to hop on my back. But that’s going to cost you $100,000 for the Peter McCallum [Cancer Centre]. And if you are prepared to hop on my back and prepared to commit, I’ll take you across the road.”

People were honking and this and that. Anyhow, we got to the other side of the road. And 10 days later, there was a cheque sitting in my office to pass on to pay the McCallum Cancer Institute for $100,000.

David and I are very proud of the fact that I offered he accepted. I was a man of my word I carried him across, and he was very much a man of his word. But I’ve never told Peter Mac how I got the $100,000.

The causes I’m most interested in are medical research and education. I’ve got a philosophy that you don’t take anything with you other than your good name that you can leave behind. We’ve got that philosophy in our family and I teach the next generation and hopefully, the generation after that understand their obligation.

As soon as the three musketeers [Guy Fowler, Matthew Grounds and Gary Weiss] spoke to me I said ‘stop’. They said ‘we haven’t finished’. And I said, ‘I’m in’. We invested $10 million in Sohn Hearts and Minds. So substantial enough for a young fellow like me.

I also was prepared to get up in the audience [at the conference] put my hand up and then bring people with me. That happened right from the start. And it made a difference. There was a good coterie of people, and we were all there for the right cause. There are too few involved in the causes.

Some of the donations [from the Lew Foundation] are anonymous. It depends if they need our name, to be able to raise more money, right? If there are leadership donors who are already committed to that cause, then they don’t need my name.

Since I’ve been a public company director, which is since the early 80s, I have never taken a director’s fee. I’ve asked the company donate the money to charity. As a director and chairman of public companies, I have never allowed the company to donate money. It’s not a privilege of the board to be able to give shareholder money away. The shareholders, once they receive their dividends, it’s their prerogative. I’m sure that many do that [donate].

I don’t believe that it’s a board’s responsibility to be able to pick one charity over another because it’s such a diverse group of investors in a company. The company doesn’t belong to the directors. In some cases, the directors might not even be shareholders.

David Paradice: Solly is very focused and targeted. He’s just a phenomenal retailer. There’s a lot of humility with him. He makes plenty of decisions. He’s a tough businessman but retailing’s a tough gig. We do catch up a lot and I do enjoy spending time with him because he gets you thinking and challenging.

We’ve known each other for quite a long period of time. We were both investors in Breville and [Paradice Investment Management] were early investors in [Lew-backed] Premier Investments as well. Breville was getting taken over, Solly had a fairly big shareholding, and we had a reasonable shareholding and between us, we blocked them.

When David Jones wasn’t going that well and Mark McInnes had just started and Solly and I were chatting about it, he suggested we have a look at it. So we did some work and we invested. So we’ve done very well out of him. He’s a great businessman and a great retailer. He’s in the weeds.

I remember coming back from the airport, and it was 8 o’clock on a Friday. Colette Garnsey used to run fashion [at Premier] for him. I was in the car with her getting a lift, and he was calling her up seeing how the day’s sales had gone, the week’s sales had gone. That was 8 o’clock on a Friday.

We’ve done a lot of business together, and he’s interested in people. He’s not aloof at all.

He got me into the Peter McCallum Institute. We were in Greece, and he was trying to get me donate some money. So I said, ‘well, if you give me a piggyback across the road I will’. Or maybe he said he’d give me a piggyback. I knew I was going to donate the money anyway, so I thought that I might as well get an amazing photo out of it.

We’ve donated quite a bit through Sohn Hearts and Minds. I didn’t realise the effect it has had until [Black Dog] wrote me a letter in October.

I just know a lot of people who have suffered from mental health and when Matty [Grounds] called me I happened to be going through the Fin Review. He asked me what charity, I was reading something and a brochure fell out of the AFR, and it was Black Dog. And that’s how Black Dog was included.

No, there’s no more trips to Greece planned!

The Financial Review is a partner for Sohn Hearts & Minds, which was held on November 17 at the Sydney Opera House. 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

The Australian Financial Review’s Related Parties column will document the lesser known and more personal connections between the country’s prominent business figures. Solomon Lew, the billionaire retailer, has known David Paradice, the high-profile fund managers, for years. Beyond investing, they share a common interest in medical research – and holidaying in Greece.

Solomon Lew: I’ve known David for about 25 years. He has always struck me as extremely competent, accredited fund manager with great principles. And it reminds me of Columbo, that TV series, the guy in the raincoat with the newspaper. He’s always got the killer question.

David has always been a very charitable individual. He’s always front and centre. David is no piker. He’s right there. He’s the type of fellow that you can bring along, he doesn’t need a lot of convincing. David knows right from wrong and is an individual with a big heart.

We were in one of the [Greek] islands, and we were going to dinner. He says, “we’re never going to be able to cross this road. It’s terrible. It’s shocking. There are no lights, motorbikes screaming everywhere.” 

I said: “David, there’s one way to get across this particular roadway. We’re going to walk across this. The only thing I can offer you then is I can offer you to hop on my back. But that’s going to cost you $100,000 for the Peter McCallum [Cancer Centre]. And if you are prepared to hop on my back and prepared to commit, I’ll take you across the road.”

People were honking and this and that. Anyhow, we got to the other side of the road. And 10 days later, there was a cheque sitting in my office to pass on to pay the McCallum Cancer Institute for $100,000.

David and I are very proud of the fact that I offered he accepted. I was a man of my word I carried him across, and he was very much a man of his word. But I’ve never told Peter Mac how I got the $100,000.

The causes I’m most interested in are medical research and education. I’ve got a philosophy that you don’t take anything with you other than your good name that you can leave behind. We’ve got that philosophy in our family and I teach the next generation and hopefully, the generation after that understand their obligation.

As soon as the three musketeers [Guy Fowler, Matthew Grounds and Gary Weiss] spoke to me I said ‘stop’. They said ‘we haven’t finished’. And I said, ‘I’m in’. We invested $10 million in Sohn Hearts and Minds. So substantial enough for a young fellow like me.

I also was prepared to get up in the audience [at the conference] put my hand up and then bring people with me. That happened right from the start. And it made a difference. There was a good coterie of people, and we were all there for the right cause. There are too few involved in the causes.

Some of the donations [from the Lew Foundation] are anonymous. It depends if they need our name, to be able to raise more money, right? If there are leadership donors who are already committed to that cause, then they don’t need my name.

Since I’ve been a public company director, which is since the early 80s, I have never taken a director’s fee. I’ve asked the company donate the money to charity. As a director and chairman of public companies, I have never allowed the company to donate money. It’s not a privilege of the board to be able to give shareholder money away. The shareholders, once they receive their dividends, it’s their prerogative. I’m sure that many do that [donate].

I don’t believe that it’s a board’s responsibility to be able to pick one charity over another because it’s such a diverse group of investors in a company. The company doesn’t belong to the directors. In some cases, the directors might not even be shareholders.

David Paradice: Solly is very focused and targeted. He’s just a phenomenal retailer. There’s a lot of humility with him. He makes plenty of decisions. He’s a tough businessman but retailing’s a tough gig. We do catch up a lot and I do enjoy spending time with him because he gets you thinking and challenging.

We’ve known each other for quite a long period of time. We were both investors in Breville and [Paradice Investment Management] were early investors in [Lew-backed] Premier Investments as well. Breville was getting taken over, Solly had a fairly big shareholding, and we had a reasonable shareholding and between us, we blocked them.

When David Jones wasn’t going that well and Mark McInnes had just started and Solly and I were chatting about it, he suggested we have a look at it. So we did some work and we invested. So we’ve done very well out of him. He’s a great businessman and a great retailer. He’s in the weeds.

I remember coming back from the airport, and it was 8 o’clock on a Friday. Colette Garnsey used to run fashion [at Premier] for him. I was in the car with her getting a lift, and he was calling her up seeing how the day’s sales had gone, the week’s sales had gone. That was 8 o’clock on a Friday.

We’ve done a lot of business together, and he’s interested in people. He’s not aloof at all.

He got me into the Peter McCallum Institute. We were in Greece, and he was trying to get me donate some money. So I said, ‘well, if you give me a piggyback across the road I will’. Or maybe he said he’d give me a piggyback. I knew I was going to donate the money anyway, so I thought that I might as well get an amazing photo out of it.

We’ve donated quite a bit through Sohn Hearts and Minds. I didn’t realise the effect it has had until [Black Dog] wrote me a letter in October.

I just know a lot of people who have suffered from mental health and when Matty [Grounds] called me I happened to be going through the Fin Review. He asked me what charity, I was reading something and a brochure fell out of the AFR, and it was Black Dog. And that’s how Black Dog was included.

No, there’s no more trips to Greece planned!

The Financial Review is a partner for Sohn Hearts & Minds, which was held on November 17 at the Sydney Opera House. 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 03, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
January 18, 2023

Claremont Global: Investment Case for Nike

Equity Mates are joined by Head of Claremont Global Bob Desmond to discuss his 2022 conference pick, Nike. In the episode Bob unpacks the key metrics, the bull case and the bear case for Nike.

Read More
January 5, 2023

Why Transurban will always be one step ahead of inflation

Loathed by motorists, but loved by investors. Transurban came under focus when Catherine Allfrey nominated the roads operator as her top pick at the recent Sohn Hearts & Minds Conference.

Read More
November 18, 2022

Behind the mega-themes shaping top stockpickers

These are the mega-themes the smartest minds in the market are now firmly getting behind which they believe can help them deliver outsized profits.

Read More
November 18, 2022

Don’t rush to invest yet, fund manager tells Sohn event

Fund manager turned anti-corruption campaigner Bill Browder is advising investors to hang on to their cash until central banks stop raising interest rates and the cost of living starts to come down.

Read More
November 18, 2022

Fund managers go global for top Sohn conference stock picks over Aussie companies

SH&M had before Friday’s event made more than $40m in collective donations to medical research.

Read More
November 18, 2022

Fundies and billionaires party in Hobart

Two hundred of Australia’s best and brightest money managers, bankers and entrepreneurs toasted the seventh Sohn Hearts and Minds conference at David Walsh’s MONA.

Read More
November 18, 2022

Hearts racing: Rich listers rendezvous for speed-dating style stock picking

A room filled with 700 of the country’s financial luminaries and billionaires is a difficult place to pitch an investment idea but it’s a great place to raise money for charity.

Read More
November 18, 2022

How MONA’s David Walsh shocked our top stock pickers

Professional gambler and arts impresario David Walsh had a brutal message for successful top money managers – you may just be lucky.

Read More
November 18, 2022

Why Sohn’s top stock pickers want investors to play it safe

Top global money managers are telling investors to steer clear of companies that don’t make money and invest instead in unloved but profitable businesses.

Read More
November 17, 2022

Five years on, what are the best Sohn stock picks to date?

Some of the top fund managers in the country will on Friday pitch their best investment ideas to the Sohn Hearts & Minds conference.

Read More
November 17, 2022

Low debt counts for everything, says Perpetual’s Aboud

Perpetual’s top stock picker Anthony Aboud makes his money running against the crowd and this is why property trusts like Charter Hall are sitting right the top his list right now.

Read More
November 17, 2022

Perpetual’s Aboud says bet on balance sheets in turbulent markets

Perpetual’s Anthony Aboud says companies with strong balance sheets will finally be rewarded for their discipline in a time of global market upheaval.

Read More
November 16, 2022

How Gerry Cardinale of RedBird Capital tries to double his money investing in sport

The owner of AC Milan and a host of other soccer, cricket, baseball and ice hockey assets is trying to double his money in the ‘resilient’ asset class.

Read More
November 14, 2022

Think outside the box for green investment opportunities

James Miller, Portfolio Manager at Firetrail Investments, believes investors need to stop seeing the global decarbonisation push as a risk – and start seeing it as an opportunity.

Read More
November 14, 2022

Tim Carleton is backing the Aussie dream all the way

Carleton’s conviction will be on full display on Friday when he makes his third appearance at the Sohn Hearts & Minds Conference, where stock-pickers share their best ideas in the name of medical research.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.